Cannabis stocks get a life thanks to Trump’s new drug pricing

957 0

Big Pharma will have to list drug prices in their TV spots

President Donald Trump may have just given the cannabis industry a huge boost; whether or not it was intentional can’t be known. Due to a decision by the US Department of Health & Human Services (HHS), pharmaceutical companies are going to be forced to make changes to their TV ads that are not going to make them happy and certainly won’t put them in a good light. As a result, cannabis could benefit and, subsequently, so could cannabis stocks.

Starting this summer, Big Pharma TV spots must include the price of the drug being advertised. A $700 epi-pen will no longer be a secret. The changes are going to force the pharmaceutical companies to come out of the closet and respond to the general public as it realizes how it has been overcharged for decades.

As a result of the increase in awareness, drug stocks should go down as more emphasis is put on cannabis and its health benefits. The timing of the change couldn’t be any better – over 70% of the general US population is in favor of marijuana reform and lawmakers on Capitol Hill are already busy trying to make those changes come to life.

The policy shift is going to bring to the forefront Big Pharma’s price gouging, putting it in front of every consumer in the country. Even those who have never once considered prescription drugs, their prices and their impact on society will now be aware of what has been going on. This is going to lead to more campaigns against Big Pharma and for cannabis, and cause federal lawmakers to have to respond. Given that 33 states, and Washington, DC, have already legalized medical marijuana, expect a flurry of legal activity over the next 18 months.